BGN-CLCN3 Fusion FISH Probe
The BGN-CLCN3 Fusion FISH Probe is used to confirm a fusion of the BGN and CLCN3 genes. The fusion of the BGN and CLCN3 genes has been associated with Liver Hepatocellular Carcinoma, and Pancreatic Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| BGN-CLCN3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| BGN-CLCN3-20-AQAQ | 20 (40 μL) | 200 μL |
|
BGN Gene Summary
This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication. [provided by RefSeq, Nov 2015]
Gene Name: Biglycan
Chromosome: CHRX: 152760346 -152775004
Locus: Xq28
CLCN3 Gene Summary
This gene encodes a member of the voltage-gated chloride channel (ClC) family. The encoded protein is present in all cell types and localized in plasma membranes and in intracellular vesicles. It is a multi-pass membrane protein which contains a ClC domain and two additional C-terminal CBS (cystathionine beta-synthase) domains. The ClC domain catalyzes the selective flow of Cl- ions across cell membranes, and the CBS domain may have a regulatory function. This protein plays a role in both acidification and transmitter loading of GABAergic synaptic vesicles, and in smooth muscle cell activation and neointima formation. This protein is required for lysophosphatidic acid (LPA)-activated Cl- current activity and fibroblast-to-myofibroblast differentiation. The protein activity is regulated by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in glioma cells. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
Gene Name: Chloride Voltage-gated Channel 3
Chromosome: CHR4: 170541671 -170644338
Locus: 4q33
Gene Diseases
The BGN CLCN3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
| Pancreatic Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|